TOP TIERMARKET NEWSWIRE
News & sentiment

BOLT BIOTHERAPEUTICS (BOLT) — News & AI sentiment

BOLT BIOTHERAPEUTICS (BOLT) news roundup. 5 stories aggregated over the last 30 days. Average 30-day sentiment is 62.6/100. Recent insider activity (SEC Form 4, 90-day window): 2 purchases totalling $4K and 3 sales totalling $128K — net selling of $124K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
5
avg sentiment 62.6/100
Insider net (90d)
$124K
2 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

BOLT news in the last 24 hours, 7 days, 30 days and 90 days

How much BOLT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBOLT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days562.6/100BOLT headlines →
Last 90 days1157.2/100BOLT headlines →

Latest stories on BOLT

Sep 17
Sep 17
Lucid, Bolt team up to deploy 25,000 robotaxis across Europe
Investing.com Markets64 · neutralproduct/pr
Sep 17
Lucid and Bolt to launch 25,000 robotaxis in Europe
Financial Times63 · neutralproduct/pr
Sep 17
Sep 17
Aug 11
Aug 11
Aug 11
Aug 11
Aug 11
Aug 11
Jun 11
Jun 11
May 19
Open BOLT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →